Nucleoside-Diphosphate Kinase
"Nucleoside-Diphosphate Kinase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that is found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6.
| Descriptor ID |
D009701
|
| MeSH Number(s) |
D08.811.913.696.650.550
|
| Concept/Terms |
Nucleoside-Diphosphate Kinase- Nucleoside-Diphosphate Kinase
- Kinase, Nucleoside-Diphosphate
- Nucleoside Diphosphate Kinase
- Nucleoside Diphosphokinases
- Diphosphokinases, Nucleoside
- Deoxynucleoside Diphosphate Kinases
- Diphosphate Kinases, Deoxynucleoside
- Kinases, Deoxynucleoside Diphosphate
- Nucleoside-Diphosphate Kinases
- Kinases, Nucleoside-Diphosphate
- Nucleoside Diphosphate Kinases
|
Below are MeSH descriptors whose meaning is more general than "Nucleoside-Diphosphate Kinase".
Below are MeSH descriptors whose meaning is more specific than "Nucleoside-Diphosphate Kinase".
This graph shows the total number of publications written about "Nucleoside-Diphosphate Kinase" by people in this website by year, and whether "Nucleoside-Diphosphate Kinase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nucleoside-Diphosphate Kinase" by people in Profiles.
-
AWD regulates timed activation of BMP signaling in intestinal stem cells to maintain tissue homeostasis. Nat Commun. 2019 07 05; 10(1):2988.
-
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics. 2002 Mar; 1(3):197-203.
-
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. Oncogene. 2001 Oct 18; 20(47):6881-90.
-
Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res. 2001 Mar 01; 61(5):2320-7.
-
Evidence for interaction between human PRUNE and nm23-H1 NDPKinase. Oncogene. 1999 Dec 02; 18(51):7244-52.
-
Urothelial differentiation and bladder cancer. Adv Exp Med Biol. 1999; 462:437-48.
-
Two-dimensional separations of the genome and proteome of neuroblastoma cells. Electrophoresis. 1996 Nov; 17(11):1741-51.
-
Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones. Clin Exp Metastasis. 1996 Mar; 14(2):95-106.
-
Nucleotides regulate the binding affinity of the recombinant type A cholecystokinin receptor in CHO K1 cells. Regul Pept. 1996 Feb 22; 61(2):87-93.
-
A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction. Oncogene. 1996 Feb 01; 12(3):659-67.